SYNLOGIC, INC. 8-K

What Happened

• Synlogic, Inc. (SYBX) announced it has withdrawn its request for a Nasdaq hearing after receiving a November 21, 2025 Notice from Nasdaq saying the company is believed to be a “public shell” and that continued listing was not warranted. Synlogic had initially timely requested a hearing on November 28, 2025 (hearing scheduled for January 20, 2026) but withdrew that request on January 16, 2026.
• Nasdaq notified the company that its shares will be suspended at the open of business on January 21, 2026, and Nasdaq will file a Form 25 with the SEC after internal procedural periods. Synlogic expects its common stock to be quoted on the OTC Markets Group, Inc. following delisting and will remain a reporting company under the Exchange Act.

Key Details

• Nasdaq Notice received: November 21, 2025; Company requested hearing: November 28, 2025; hearing date set for January 20, 2026; withdrawal of hearing request: January 16, 2026.
• Suspension effective at open of business on January 21, 2026; Nasdaq to file Form 25 after internal procedures.
• Company expects post-delisting quotation on the OTC Markets and will continue to file SEC reports.
• Filing includes standard forward-looking statements and cautions investors to review Synlogic’s SEC filings for risks.

Why It Matters

• For investors, delisting from Nasdaq and a move to OTC typically reduces liquidity, visibility, and eligibility for many institutional investors and brokerage trading programs, which can increase volatility and widen bid-ask spreads.
• Synlogic remaining a reporting company means SEC filings and investor disclosures will continue, but trading and market access conditions for the stock will likely change once suspension and OTC quotation occur.